Kyverna Therapeutics, a clinical-stage biopharmaceutical company focused on CAR T-cell therapy for autoimmune conditions, sought a partner to support their stakeholder engagement and clinical trial recruitment efforts. 

CURA partnered with Kyverna to engage leading patient influencers in the autoimmune space to increase awareness of CAR T-cell therapy and Kyverna’s work. This resulted in lasting partnerships and increased engagement among high-value patient communities.